160 related articles for article (PubMed ID: 38129382)
1. UBE2O reduces the effectiveness of interferon-α via degradation of IFIT3 in hepatocellular carcinoma.
Li H; Liu Y; Cheng C; Wu Y; Liang SH; Wu L; Wang H; Tu CY; Yao HH; Meng FZ; Zhang B; Wang W; Wang JB; Liu LX
Cell Death Dis; 2023 Dec; 14(12):854. PubMed ID: 38129382
[TBL] [Abstract][Full Text] [Related]
2. Hepatic IFIT3 predicts interferon-α therapeutic response in patients of hepatocellular carcinoma.
Yang Y; Zhou Y; Hou J; Bai C; Li Z; Fan J; Ng IOL; Zhou W; Sun H; Dong Q; Lee JMF; Lo CM; Man K; Yang Y; Li N; Ding G; Yu Y; Cao X
Hepatology; 2017 Jul; 66(1):152-166. PubMed ID: 28295457
[TBL] [Abstract][Full Text] [Related]
3. UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.
Ma M; Zhang C; Cao R; Tang D; Sang X; Zou S; Wang X; Xu H; Liu G; Dai L; Tian Y; Gao X; Fu X
Oncogene; 2022 Nov; 41(48):5199-5213. PubMed ID: 36273042
[TBL] [Abstract][Full Text] [Related]
4. IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2
Xu S; Huang J; Xun Z; Li S; Fu Y; Lin N; Wu W; Chen T; Liu C; Ou Q
Microbiol Spectr; 2022 Dec; 10(6):e0155722. PubMed ID: 36314949
[TBL] [Abstract][Full Text] [Related]
5. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.
Chen S; Yang J; Zhang Y; Duan C; Liu Q; Huang Z; Xu Y; Zhou L; Xu G
J Biol Chem; 2018 Jul; 293(29):11296-11309. PubMed ID: 29871923
[TBL] [Abstract][Full Text] [Related]
7. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
Ullah K; Zubia E; Narayan M; Yang J; Xu G
FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
[TBL] [Abstract][Full Text] [Related]
8. High Level of Ubiquitin Conjugate Enzyme E2O Indicates Poor Prognosis of Patients with Hepatocellular Carcinoma.
Lan SY; Ding Y; Wang C; Fang J; Ren C; Liu JL; Kang H; Chang Y
Curr Med Sci; 2023 Feb; 43(1):93-103. PubMed ID: 36269535
[TBL] [Abstract][Full Text] [Related]
9. A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy.
Vila IK; Yao Y; Kim G; Xia W; Kim H; Kim SJ; Park MK; Hwang JP; González-Billalabeitia E; Hung MC; Song SJ; Song MS
Cancer Cell; 2017 Feb; 31(2):208-224. PubMed ID: 28162974
[TBL] [Abstract][Full Text] [Related]
10. UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance.
Huang Y; Yang X; Lu Y; Zhao Y; Meng R; Zhang S; Dong X; Xu S; Wu G
Cell Death Differ; 2021 Feb; 28(2):671-684. PubMed ID: 32901121
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
12. Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression.
Chikhalya A; Dittmann M; Zheng Y; Sohn SY; Rice CM; Hearing P
mBio; 2021 Dec; 12(6):e0282921. PubMed ID: 34724821
[TBL] [Abstract][Full Text] [Related]
13. UBE2O is a quality control factor for orphans of multiprotein complexes.
Yanagitani K; Juszkiewicz S; Hegde RS
Science; 2017 Aug; 357(6350):472-475. PubMed ID: 28774922
[TBL] [Abstract][Full Text] [Related]
14. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
[TBL] [Abstract][Full Text] [Related]
15. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
16. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
17. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
Vila IK; Park MK; Setijono SR; Yao Y; Kim H; Badin PM; Choi S; Narkar V; Choi SW; Chung J; Moro C; Song SJ; Song MS
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292296
[TBL] [Abstract][Full Text] [Related]
18. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
19. A new duet in cancer biology: AMPK the typical and UBE2O the atypical.
Vila IK; Song SJ; Song MS
Mol Cell Oncol; 2017; 4(3):e1304846. PubMed ID: 28616582
[No Abstract] [Full Text] [Related]
20. UBE2O remodels the proteome during terminal erythroid differentiation.
Nguyen AT; Prado MA; Schmidt PJ; Sendamarai AK; Wilson-Grady JT; Min M; Campagna DR; Tian G; Shi Y; Dederer V; Kawan M; Kuehnle N; Paulo JA; Yao Y; Weiss MJ; Justice MJ; Gygi SP; Fleming MD; Finley D
Science; 2017 Aug; 357(6350):. PubMed ID: 28774900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
